European heart journal. Quality of care & clinical outcomes
The bleeding costs of intensive versus less intensive antithrombotic strategies: a meta-regression analysis.
Sten E Deurvorst, Esther M E El-Hage, Nienke van Wingerden, Kirsten A Ziesemer, Jonne J Sikkens, Yvo M Smulders
Published: 202510.1093/ehjqcco/qcaf128
Abstract
OBJECTIVES: Antithrombotic therapy is a cornerstone of secondary prevention of atherosclerotic cardiovascular disease (ASCVD). The main drawback of antithrombotic therapy is the associated bleeding risk. The correlation between the magnitude of antit…
Preview only. Read the full abstract at the source